Literature DB >> 30472657

Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the TYR gene.

Solene Monfermé1, Eulalie Lasseaux2, Catherine Duncombe-Poulet3, Christian Hamel4, Sabine Defoort-Dhellemmes5, Isabelle Drumare5, Xavier Zanlonghi6, Hélène Dollfus7, Yaurama Perdomo7, Dominique Bonneau8, Jean-François Korobelnik9, Claudio Plaisant2, Vincent Michaud2, Perrine Pennamen2,10, Caroline Rooryck-Thambo2,10, Fanny Morice-Picard11, Clement Paya12, Benoit Arveiler2,10.   

Abstract

AIM: Oculocutaneous albinism type 1 (OCA1) is due to TYR mutations. c.1205G>A/p.Arg402Gln (R402Q) is a thermosensitive variant of the TYR gene that has been reported to be responsible for mild forms of OCA1. The aim of our study was to define the phenotype associated with this variant.
METHODS: In our retrospective series, among 268 patients diagnosed with OCA1, 122 (45.5%) harboured one pathogenic variant of TYR, and the R402Q variant ensured to be in trans by segregation analysis in 69 patients (25.7%), constituting the 'R402Q-OCA1' group. 146 patients harboured two pathogenic variants of the TYR gene other than R402Q. Clinical records were available for 119 of them, constituting the 'Classical-OCA1' group.
RESULTS: Most R402Q-OCA1 patients presented with white or yellow-white hair at birth (71.43%), blond hair later (46.97%), a light phototype but with residual pigmentation (69.64%), and blue eyes (76.56%). Their pigmentation was significantly higher than in the classical-OCA1 group. All patients from the R402Q-OCA1 group presented with ocular features of albinism. However the prevalence of photophobia (78.13%) and iris transillumination (83.87%) and the severity scores of iris transillumination, retinal hypopigmentation and foveal hypoplasia were lower in the R402Q-OCA1 group. Visual acuity was higher in the R402Q-OCA1 group (0.38±0.21 logarithm of the minimum angle of resolution vs 0.76±0.24). Investigations concerning a possible additive effect of the c.575C>A/p.Ser192 (S192Y) variant of TYR in cis with R402Q, suggested by others, showed no significant impact on the phenotype.
CONCLUSION: The R402Q variant leads to variable but generally mild forms of albinism whose less typical presentation may lead to underdiagnosis. © Author(s) (or their employer(s)) [year]. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  zzm321990TYR gene; R402Q (c.1205G>A/p.Arg402Gln); albinism; foveal hypoplasia; genotype-phenotype correlation; hypopigmentation; nystagmus

Mesh:

Substances:

Year:  2018        PMID: 30472657     DOI: 10.1136/bjophthalmol-2018-312729

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

1.  The contribution of common regulatory and protein-coding TYR variants to the genetic architecture of albinism.

Authors:  Vincent Michaud; Eulalie Lasseaux; David J Green; Dave T Gerrard; Claudio Plaisant; Tomas Fitzgerald; Ewan Birney; Benoît Arveiler; Graeme C Black; Panagiotis I Sergouniotis
Journal:  Nat Commun       Date:  2022-07-08       Impact factor: 17.694

2.  Aberrant visual population receptive fields in human albinism.

Authors:  Ethan J Duwell; Erica N Woertz; Jedidiah Mathis; Joseph Carroll; Edgar A DeYoe
Journal:  J Vis       Date:  2021-05-03       Impact factor: 2.240

3.  Clinical utility gene card for oculocutaneous (OCA) and ocular albinism (OA)-an update.

Authors:  Abdullah Aamir; Helen J Kuht; Karen Grønskov; Brian P Brooks; Mervyn G Thomas
Journal:  Eur J Hum Genet       Date:  2021-01-27       Impact factor: 5.351

4.  Assessing Foveal Structure in Individuals with TYR R402Q and S192Y Hypomorphic Alleles.

Authors:  Gelique D Ayala; Rachel E Linderman; Robert K Valenzuela; Erica N Woertz; Murray Brilliant; Sergey Tarima; Joseph Carroll
Journal:  Ophthalmol Sci       Date:  2021-11-17

5.  Prospective Study of the Phenotypic and Mutational Spectrum of Ocular Albinism and Oculocutaneous Albinism.

Authors:  Hwei Wuen Chan; Elena R Schiff; Vijay K Tailor; Samantha Malka; Magella M Neveu; Maria Theodorou; Mariya Moosajee
Journal:  Genes (Basel)       Date:  2021-03-30       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.